Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Disc Medicine

Tracked across 2 events · 15 articles · First seen Jan 29, 2026 · Last active Mar 30, 2026

Sentiment
-20
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
2 -70
Regulatory
Disc Medicine is facing a securities fraud investigation by Pomerantz LLP after its stock price fell due to concerns flagged by the United States===Food and Drug Administration regarding a drug under development. This investigation could lead to legal liabilities and further damage its reputation and stock value.
Jan 29, 2026 · 8 articles
4 30
Regulatory
Disc Medicine's shares rose about 10% in after-market trading. This surge is linked to the departure of Vinay Prasad, under whose leadership the United States===Food and Drug Administration had rejected Disc Medicine's treatment despite it receiving a Commissioner's National Priority Voucher.
Mar 06, 2026 · 7 articles
NEWSDESK
Track Disc Medicine live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.